Patents by Inventor Mitrabhanu MOHANTY

Mitrabhanu MOHANTY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions comprising phenylaminopyrimidine derivative
    Patent number: 10383872
    Abstract: An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.
    Type: Grant
    Filed: January 30, 2016
    Date of Patent: August 20, 2019
    Assignee: NATCO PHARMA LTD
    Inventors: Durga Maheswari Parvataneni, Mitrabhanu Mohanty, Venkata Satyanarayana Appadwedula, Kali Satya Bhujanga Rao Adibhatla, Venkaiah Chowdary Nannapaneni
  • Pharmaceutical compositions comprising phenylaminopyrimidine derivative
    Patent number: 10350209
    Abstract: An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.
    Type: Grant
    Filed: January 30, 2016
    Date of Patent: July 16, 2019
    Assignee: NATCO PHARMA LTD
    Inventors: Durga Maheswari Parvataneni, Mitrabhanu Mohanty, Venkata Satyanarayana Appadwedula, Kali Satya Bhujanga Rao Adibhatla, Venkaiah Chowdary Nannapaneni
  • PHARMACEUTICAL COMPOSITIONS COMPRISING PHENYLAMINOPYRIMIDINE DERIVATIVE
    Publication number: 20190015412
    Abstract: An oral pharmaceutical formulation containing an effective amount of NRC-AN-019 including its pharmaceutically acceptable salts and polymorphs thereof, by dispersing in a polymer system in a final state of subdivision to enhance oral bioavailability. It also relates to processes for the preparation of such compositions and using those compositions for the treatment of Chronic Myeloid Leukemia and other tumors such as head and neck cancer, prostate cancer and the like.
    Type: Application
    Filed: January 30, 2016
    Publication date: January 17, 2019
    Inventors: Durga Maheswari PARVATANENI, Mitrabhanu MOHANTY, Venkata Satyanarayana APPADWEDULA, Kali Satya Bhujanga Rao ADIBHATLA, Venkaiah Chowdary NANNAPANENI